21 CFR · Food and Drugs
§ 520.1858 — Potassium bromide chewable tablets.
eCFR · current through Jul 29, 2026
§ 520.1858 Potassium bromide chewable tablets.
(a)Specifications. Each chewable tablet contains 250 or 500 milligrams (mg) potassium bromide.
(b)Sponsor. See No. 055246 in § 510.600(c) of this chapter.
(c)Conditions of use—
(1)Amount. Administer 25 to 68 mg per kilogram (11 to 31 mg per pound) of body weight. The dosage should be adjusted based on monitoring of clinical response of the individual patient.
(2)Indications for use. For the control of seizures associated with idiopathic epilepsy in dogs.
(3)Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[91 FR 41560, July 7, 2026]
Free access — add to your briefcase to read the full text and ask questions with AI
21 C.F.R. § 520.1858 (Potassium bromide chewable tablets.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Related
§ 510.600
21 C.F.R. § 510.600
Nearby Sections
11
§ 520.1803
Piperazine citrate capsules.§ 520.1806
Piperazine suspension.§ 520.1840
Poloxalene.§ 520.1855
Ponazuril.§ 520.1858
Potassium bromide chewable tablets.§ 520.1860
Pradofloxacin.§ 520.1870
Praziquantel tablets.§ 520.1871
Praziquantel and pyrantel.§ 520.1880
Prednisolone.